Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction to: Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)

The Original Article was published on 28 June 2021

Correction to: Genetics in Medicine 2021; https://doi.org/10.1038/s41436-021-01247-1; published online 28 June 2021

Due to a processing error the sentence “Rather, it only assesses the risk for developing a disorder.” was given incorrect.

The original article has been corrected.

Author information

Affiliations

Consortia

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

ACMG Board of Directors. Correction to: Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23, 2226 (2021). https://doi.org/10.1038/s41436-021-01275-x

Download citation

Search

Quick links